市场调查报告书
商品编码
1184273
血管闭合装置全球市场规模,份额和行业趋势分析报告:按应用(腹腔镜手术,普外科),最终用途,产品(仪器,发电机,配件),区域展望和预测2022-2028Global Vessel Sealing Devices Market Size, Share & Industry Trends Analysis Report By Application (Laparoscopic Surgery and General Surgery), By End Use, By Product (Instruments, Generators and Accessories), By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,血管闭合装置的全球市场规模预计将达到 26 亿美元,在预测期内以 9.7% 的复合年增长率增长。
传统的单极装置具有较大的横向热扩散和不精确且微弱的血管闭合。 现代外科实践中最常用的两种止血能量装置是双极和超声波。
现代双极设备阻止电流通过设备的爪传播,密封血管,并使用电热能最大限度地减少对周围组织的损害。 另一方面,超声波设备使用高频振动而不是电流,但能量在设备的钳口之间传输得非常薄。
COVID-19 影响分析
在这种情况下,医疗机构实行行动限制,学术团体和监管部门发出推迟择期手术的建议,绝大部分国家被封锁。 结果,对容器密封装置的需求减少了。 随着COVID-19疫情进入恢復期,腹腔镜手术有望恢復正常。 此外,COVID-19 大流行推动了腹腔镜器械的一次性使用。 由于腹腔镜手术是一次性的,因此不易发生交叉污染,具有在大流行期间可以使用的优势。 因此,自大流行以来,血管闭合装置市场迅速復苏。
市场增长因素
新技术驱动全球市场
对微创血管闭合装置的需求是由妇科、泌尿科、心脏病学、骨科和普通外科领域不断增长的需求推动的。 新的软件和復杂的血管闭合装置的开发实现了连续的血管闭合工作流程,使外科医生能够高效地执行快速、准确和无痛的手术。
对微创手术的兴趣与日俱增
与传统的开放手术相比,微创手术的特点是恐惧感小。 传统的腹腔镜手术既困难又痛苦。 该手术使用小型专用仪器和通过小切口插入的微创腹腔镜照相机。 微创手术后,患者可以恢復得更快,痛苦也更少。 随着微创手术的普及,血管封闭装置的市场可能会扩大。
市场障碍
血管闭合装置的问题
虽然血管内密封装置有许多优点,但一些缺点可能会阻碍行业的发展。 由于侧向热能分布,血管密封方法可能会损伤神经、输尿管和肠道。 这种横向能量分散会损坏 2 毫米的组织。 在 2020 年的一篇文章中,Shozaburo Oyama 说 LigaSure 可能导致手术困难。 LigaSure 无法挤压重要的血管和神经,因为厚而緻密的组织无法容纳在刀片之间。 还有血管密封装置的问题,预计会阻碍业务发展。
应用展望
血管固定器械市场按应用细分为腹腔镜手术和普外科。 到 2021 年,普外科将在血管闭合器市场中占据很大的收入份额。 这是由于其在乙状结肠切除术和盲肠切除术等手术中的频繁选择。 这种偏好可以解释为这些手术比腹腔镜手术的成功率更高。 普外科手术价格高、术后住院时间长,市场占有率小。
产品展望
血管闭合装置市场按产品细分为发生器、仪器和配件。 2021 年,发电机细分市场在容器密封行业中占据了重要的收入份额。 双极和血管封闭治疗由电外科发电机提供动力,也称为血管封闭发电机。 能量装置越来越多地用于血管封闭和消融的微创手术。 这些发生器在预定的时间段内向血管输送精确的能量和电极压力,以实现血管腔的完全和长期融合。
结束使用 Outlook
血管闭合装置市场根据最终用户细分为门诊手术中心、医院和专科诊所。 2021 年血管闭合器械市场将在医院领域占据最大的收入份额。 这是在医院进行更多手术的结果。 特别是可重复使用的容器密封系统可为最终用户提供高效率和成本节约。 与一次性装置相比,在全颈翻修手术中使用的可重复使用的血管闭合装置可以显着降低医疗成本。
区域展望
按地区划分,血管闭合装置市场分为北美、欧洲、亚太地区和 LAMEA。 2021年,北美地区主导了血管闭合器市场。 在美国和加拿大,拥有最先进技术的重要公司和医院占据了该地区的重要市场份额。 此外,由于不良的饮食习惯、对即食零食的渴望、缺乏运动、压力大的生活方式以及相当大的人口老龄化,美国慢性疾病的患病率正在上升。这促进了市场扩张。
The Global Vessel Sealing Devices Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 9.7% CAGR during the forecast period.
By totally occluding the blood vessel and denaturing the collagen and elastin in the vessel wall, vessel sealing devices are utilized to seal the vessel wall. The most popular energy-based surgical instruments include hybrid, ultrasonic, and bipolar.
In both open and laparoscopic operations, energy-based vascular sealing devices (VSDs) have been created to speed up dissection and hemostasis. With less blood loss and shorter operating periods, these technologies allow surgeons to increase the effectiveness and safety of surgeries. In modern medicine, there is a constant demand for technological advancement to manufacture high-quality VSDs with more accurate vascular sealing quality and less heat harm to surrounding tissues.
Traditional monopolar devices have increased lateral heat spread and uncertain, weak vessel sealing. The two types of hemostatic energy devices that are most frequently employed in modern surgical practice are bipolar and ultrasonic ones.
Modern bipolar devices stop electric current from spreading through the device's jaws, sealing blood vessels and minimizing damage to the tissues around them with electrothermal energy. In contrast, ultrasonic devices use high-frequency vibrations rather than electrical current, but the energy can only be transmitted very thinly between the device's jaws.
COVID-19 Impact Analysis
Movement restrictions were implemented, and the majority of countries went into lockdown as academic societies and regulatory authorities advised delaying elective surgical procedures. All of this led to a decline in the demand for vessel sealing devices. It is anticipated that laparoscopic device procedures would return to normal as the COVID-19 pandemic's recovery phase gets underway. Additionally, the COVID-19 pandemic promoted the use of disposable laparoscopic instruments. Cross-contamination is prevented by single-use laparoscopic instruments, which proved to be an advantageous circumstance for their use throughout the COVID-19 pandemic. As a result, the market for vessel sealing devices has quickly recovered since the pandemic.
Market Growth Factors
New Technologies To Drive The Global Market
The demand for minimally invasive vessel sealing devices has been driven by the rise in gynecological, urological, cardiology, orthopedic, and general surgery needs. A continuous vessel-sealing device workflow is delivered through the development of new software and sophisticated vessel-sealing devices, allowing the surgeon to do quick, accurate, painless surgeries with increased efficiency.
Rising Interest In Minimally Invasive Procedures
Compared to traditional open surgeries, minimally invasive surgeries are significantly less frightening. Traditional procedures carried out using standard laparoscopic tools can be difficult and distressing. The procedure is carried out with the assistance of specialized, smaller equipment and minimally invasive laparoscopic cameras that are placed through smaller incisions. After minimally invasive operations, patients can recover more quickly and with less pain. The market for vessel sealing devices may expand as minimally invasive operations become more popular.
Market Restraining Factors
Problems With Using Vessel Sealing Devices
Despite the many advantages of vessel sealing systems, some disadvantages can prevent the industry from expanding. Vessel sealing methods can damage nerves, ureters, and bowels as a result of lateral thermal energy distribution. 2 mm of tissue is damaged by this lateral energy dispersion. In a 2020 essay, Shosaburo Oyama said that LigaSure could lead to surgical difficulties. Due to the inability of thick, dense tissues to fit between blades, LigaSure is unable to clamp vital blood vessels and nerves. It is anticipated that issues with vessel sealing devices may hinder the business.
Application Outlook
On the basis of Application, the Vessel Sealing Devices Market is divided into Laparoscopic Surgery and General Surgery. In the market for vessel sealing devices in 2021, the general surgery sector accounted for a sizeable revenue share. This is due to the fact that it is frequently chosen in procedures like sigmoidectomies and appendectomies. This preference may be explained by the superior success rate of these procedures over laparoscopy. General procedures have a small market share due to their high price and extended post-operative hospital stay.
Product Outlook
Based on the product, the vessel sealing devices market is divided classified into generators, instruments, and accessories. In 2021, the generators market segment showcased the significant revenue share in the vessel sealing industry. Bipolar and vessel sealing treatments are powered by electrosurgical generators, also referred to as vessel sealing generators. Energy devices are increasingly used in minimally invasive surgery for vessel sealing and dissection. These generators give accurate energy and electrode pressure to vessels for a predefined period of time in order to accomplish a full and long-lasting fusion of the vessel lumen.
End-use Outlook
Based on End-use, the market for vessel sealing devices is segmented into ambulatory surgery centers, hospitals, and specialized clinics. The market for vessel sealing devices in 2021 saw the biggest revenue share in the hospital sector. This is a result of more procedures being carried out in hospital settings. Reusable vessel sealing systems, in particular, provide end users with greater effectiveness and cost savings. Compared to disposable devices, reusable vascular sealing devices used during modified total neck dissection operations can dramatically lower medical expenses.
Regional Outlook
By geography, the vessel sealing devices market is categorized into North America, Europe, Asia Pacific, and LAMEA. In 2021, the North American region dominated the vessel sealing devices market. The presence of significant firms and hospitals with cutting-edge technology in the United States and Canada accounts for the region's considerable market share. Additionally, the rising prevalence of chronic medical disorders in the US as a result of bad eating habits, a desire for quick-to-prepare snacks, a lack of exercise, a stressful lifestyle, and a sizable older population is encouraging market expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, B. Braun Melsungen AG, Johnson & Johnson, Intuitive Surgical, Inc., Hologic, Inc. (Bolder Surgical), Erbe Elektromedizin GmbH, BOWA-electronic GmbH & Co. KG, OmniGuide, Inc., and KLS Martin Group.
Strategies deployed in Vessel Sealing Devices Market
Sep-2022: Olympus Corporation introduced THUNDERBEAT Open Fine Jaw Type X surgical energy devices to support safer procedures for open surgery. The product is designed to deliver ultrasonic and bipolar energy concurrently that allow genuine vessel division and sealing, speedy hemostatic cutting and easy dissection.
Jan-2022: Erbe Elektromedizin launched Biclamp Knife 220, a product designed to seal and cut vessels during surgical procedures and simplify the surgery. The product built with the capability to anatomize close to critical structures, seal vessels up to 7mm in diameter, manage diffuse bleedings of larger surface areas as well as stop inadvertent thermal effects to adjoining tissue as the temperature on the back of the jaws would be about below 40°C.
Nov-2021: Hologic, Inc. acquired Bolder Surgical to add dissecting devices, vessel sealing, and dividing to its surgical portfolio. With this acquisition, all the Bolder's devices would be added to the Hologic product offering including JustRight 3mm vessel sealer, JustRight 5mm stapler, and CoolSeal vessel sealing suite. Additionally, this would enhance the company's OB/GYN specialists.
Sep-2021: Olympus announced the launch of POWERSEAL, an Advanced Bipolar Surgical Energy single-use Devices. This launch strengthens the Surgical suite, the device is built with the feature of efficient and strong sealing of vessels, Minimal thermal spread with low exterior jaw temperature and Fast cool-down times, Multifunctional capabilities as well as dependability of 3x systolic blood pressure.
Jan-2021: Bolder Surgical introduced the CoolSeal Vessel Sealing platform, with an aim to enlarge the offering of vessel sealing products. The platform launch contains the CoolSeal generator, a 3mm CoolSeal Mini vessel sealer, and the CoolSeal Trinity, a new 5 mm laparoscopic vessel sealer surgical instrument used for urological, gynecological, and general surgery. CoolSeal Trinity contains 360-degree capability with dual-action jaws that allows quick sealing time and precise dissection along with the least thermal distribution surrounding major structures.
Jul-2020: BOWA Medical announced an agreement with Lexington Medical, a supplier of minimally-invasive surgical stapling solutions. Under the agreement, the LOTUS system, made by BOWA Medical, and AEON Endostapler, made by Lexington Medical would be marketed jointly by both companies globally. This would strengthen their best-in-class manufacturing and product leadership globally.
Dec-2019: Intuitive received FDA approval for SynchroSeal and E-100 generator that would be used in sealing procedures. SynchroSeal was a robotic system sealing instrument used to transect tissue whereas the E-100 generator provides power to SynchroSeal. The products were designed to empower surgeons to carry out transaction with a single pedal press and quick one-step sealing.
Apr-2018: Medtronic PLC launched LigaSure exact dissector, which offers two times faster cooling with precise dissection and superior access. The newly launch product is based on LigaSure™ vessel sealing technology, which makes it easy to seal and cut as well as, with its fine, curved jaw maximizes the line of sight.
Market Segments covered in the Report:
By Application
By End Use
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures